Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2

Archives of Neurology

Volumn 64, Issue 7, 2007, Pages 1042-1044

  Simon, David K ^a,e   Zheng, Kangni ^a   Velázquez, Luis ^b   Santos, Nieves ^b   Almaguer, Luis ^b   Figueroa, K Pattie ^c   Pulst, Stefan M ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL COMPLEX 1; NUCLEIC ACID BINDING PROTEIN; OXIDOREDUCTASE; PROTEIN; SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CUBA; FISHER EXACT TEST; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; ONSET AGE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN CHEMISTRY; CUBA; DNA REPEAT EXPANSION; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 34447267684     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.7.1042     Document Type: Article

References (11)

1. Pulst SM. Spinocerebellar ataxia. In: Pulst SM, ed. Genetics of Movement Disorders. San Diego, CA: Academic Press; 2003:47-53.
2. Koshy BT, Zoghbi HY. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol. 1997;7(3):927-942.
3. Pulst SM, Santos N, Wang D, et al. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain. 2005;128(pt 10):2297-2303.
4. Pandolfo M. Friedreich's ataxia: clinical aspects and pathogenesis. Semin Neurol. 1999;19(3):311-321.
5. Gardian G, Vecsei L. Huntington's disease: pathomechanism and therapeutic perspectives. J Neural Transm. 2004;111(10-11):1485-1494.
6. Calabrese V, Lodi R, Tonon C, et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci. 2005;233(1-2):145-162.
7. van der Walt JM, Nicodemus KK, Martin ER, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003;72(4):804-811.
8. Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology. 2000;54(3):703-709.
9. van de Warrenburg BP, Hendriks H, Durr A, et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol. 2005;57(4):505-512.
10. Huerta C, Castro MG, Coto E, et al. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci. 2005;236(1-2):49-54.
11. Ghezzi D, Marelli C, Achilli A, et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet. 2005;13(6):748-752.